Shopping Cart

Your shopping cart is currently empty

Oxyphenisatine

Name: Oxyphenisatine
Brand: TargetMol
SKU: T7071
Price: 29 USD
Availability: InStock
Rating: 5 (10 reviews)

Copy Product Info

🥰Excellent

Catalog No. T7071Cas No. 125-13-3

Alias Oxyphenisatin

Oxyphenisatine (Oxyphenisatin), along with related bisacodyl, sodium picosulfate, and phenolphthalein, isa precursor of oxyphenisatine, which has anticancer activity. Oxyphenisatine is often used as a laxative and can cause liver damage when used long-term.

Oxyphenisatine

Copy Product Info

🥰Excellent

Purity: 97.35%

Catalog No. T7071Alias OxyphenisatinCas No. 125-13-3

Pack Size	Price	USA Warehouse	Global Warehouse	Quantity
10 mg	$29	In Stock	In Stock
1 mL x 10 mM (in DMSO)	$44	In Stock	In Stock

Add to Cart

Add to Quotation

In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]

All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Questions

Batch Information

Select Batch

Purity:97.35%

Appearance:Solid

Color:Yellow

Resource Download

COA HPLC HNMR

Product Introduction

Bioactivity

Description	Oxyphenisatine (Oxyphenisatin), along with related bisacodyl, sodium picosulfate, and phenolphthalein, isa precursor of oxyphenisatine, which has anticancer activity. Oxyphenisatine is often used as a laxative and can cause liver damage when used long-term.
In vitro	Oxyphenisatin exhibits antiproliferative properties. Oxyphenisatin acetate (OXY, NSC 59687) functions as the pro-drug for oxyphenisatin. OXY suppresses the growth of breast cancer cell lines MCF7, T47D, HS578T, and MDA-MB-468 (IC 50 =0.8, 0.6, 2.1, 1.8 μM). This impact is linked to specific inhibition of translation, accompanied by swift phosphorylation of the nutrient-sensing eukaryotic translation initiation factor 2α (eIF2α) kinases, GCN2, and PERK.[1]
In vivo	Toxicity studies indicate that mice exhibit tolerance to IP administration of OXY at 300 mg/kg once daily or 200 mg/kg twice daily. The administration of OXY at 300 mg/kg IP once daily for 10 days leads to noticeably smaller tumors from day 33 to day 52.[1]
Synonyms	Oxyphenisatin

Chemical Properties

Molecular Weight	317.34
Formula	C₂₀H₁₅NO₃
Cas No.	125-13-3
Smiles	Oc1ccc(cc1)C1(C(=O)Nc2ccccc12)c1ccc(O)cc1
Relative Density.	1.352g/cm3

Storage & Solubility Information

Storage

Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Solubility Information

DMSO: 90 mg/mL (283.61 mM), Sonication is recommended.

In Vivo Formulation

10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (10.4 mM), Sonication is recommended.

Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.

Solution Preparation Table

DMSO

	1mg	5mg	10mg	50mg
1 mM	3.1512 mL	15.7560 mL	31.5119 mL	157.5597 mL
5 mM	0.6302 mL	3.1512 mL	6.3024 mL	31.5119 mL
10 mM	0.3151 mL	1.5756 mL	3.1512 mL	15.7560 mL
20 mM	0.1576 mL	0.7878 mL	1.5756 mL	7.8780 mL
50 mM	0.0630 mL	0.3151 mL	0.6302 mL	3.1512 mL
100 mM	0.0315 mL	0.1576 mL	0.3151 mL	1.5756 mL

Calculator

Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:

For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments

and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent

10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH₂O , the resulting working solution concentration would be 2 mg/mL.

Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSO TargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSO TargetMol | reagent stock solution to 400 μL PEG300 and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH₂O TargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.

All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc